[Cisplatin drug therapy. Antiemetic treatment. Experiences with the use of high-dose metoclopramide combined with chlopromazine and prochlorperazine].
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use*; D002945:Cisplatin / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D011346:Prochlorperazine / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D005047:Etoposide; D008787:Metoclopramide; D002945:Cisplatin; D002746:Chlorpromazine; D011346:Prochlorperazine
Cisplatin kjemoterapi. Antiemetisk behandling. Erfaring med bruk av høydose metoklopramid kombinert med klorpromazin og proklorperazin.